Tabla de Contenidos: “…LA INFECCIÓN POR VHB: UN PROBLEMA DE SALUD A NIVEL MUNDIAL -- RESUMEN -- CONTEXTO GENERAL DE LOS ESTUDIOS EPIDEMIOLÓGICOS DEL VIRUS DE LA HEPATITIS B (VHB) -- VÍAS DE TRANSMISIÓN -- Via perinatal -- Vía percutánea -- Vía sexual -- Vía parenteral -- Grupos y factores de riesgo -- PANORAMA MUNDIAL DEL VHB -- Regiones de alta endemia -- Regiones de endemia intermedia -- Regiones de baja endemia -- Epidemiología de Hepatitis B en Latinoamérica -- EPIDEMIOLOGÍA DE HEPATITIS B EN MÉXICO -- Cambios en el perfil epidemiológico -- CONCLUSIONES -- REFERENCIAS BIBLIOGRÁFICAS…”

Tabla de Contenidos: “…From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis -- The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases -- The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients -- The natural course of non-alcoholic fatty liver disease -- Analysis of socioeconomic status and other factors affecting patient-graft survival in patients undergoing liver transplantation -- Hepatitis E update -- A rare disease that presents with acute severe hepatitis: Kikuchi-Fujimoto disease…”

Tabla de Contenidos: “…Approach -- Evaluating biological mechanisms of adverse events -- Measles, mumps, and rubella vaccine -- Varicella virus vaccine -- Influenza vaccine -- Hepatitis A vaccine -- Hepatitis B vaccine -- Human papillomavirus vaccine -- Diphtheria toxoid-, tetanus toxoid-, and acellular pertussis-containing vaccines -- Meningococcal vaccine -- Injection-related adverse events -- Concluding comments…”

Tabla de Contenidos: “…TRASTORNOS DE LA MOTILIDAD ESOFÁGICA -- DIAGNÓSTICO -- TRATAMIENTO -- MONITOREO/SEGUIMIENTO -- REFERENCIAS -- 13: Trastornos gástricos -- ENFERMEDAD POR ÚLCERA PÉPTICA -- DIAGNÓSTICO -- TRATAMIENTO -- COMPLICACIONES -- ADENOCARCINOMA GÁSTRICO -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- TRATAMIENTO -- TUMORES DEL ESTROMA GASTROINTESTINAL -- PRINCIPIOS GENERALES -- TRATAMIENTO -- LINFOMA GÁSTRICO -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- TRATAMIENTO -- REFERENCIAS -- 14: Trastornos del intestino delgado -- INTRODUCCIÓN -- MALABSORCIÓN -- DIAGNÓSTICO -- ESPRUE CELIACO -- TRATAMIENTO -- CRECIMIENTO BACTERIANO EXCESIVO EN EL INTESTINO DELGADO (CBEID) -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- TRATAMIENTO -- SÍNDROME DE INTESTINO CORTO (SIC) -- DIAGNÓSTICO -- TRATAMIENTO -- NEOPLASIAS DEL INTESTINO DELGADO -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- TRATAMIENTO -- VIGILANCIA/SEGUIMIENTO -- RESULTADOS/PRONÓSTICO -- 15: Neoplasias del colon -- PRINCIPIOS GENERALES -- TRATAMIENTO -- SEGUIMIENTO -- CONSIDERACIONES ESPECIALES -- REFERENCIAS -- 16: Enfermedad inflamatoria intestinal -- PRINCIPIOS GENERALES -- CONSIDERACIONES ESPECIALES -- VIGILANCIA/SEGUIMIENTO -- RESULTADO/PRONÓSTICO -- REFERENCIAS -- 17: Síndrome de intestino irritable -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- REFERENCIAS -- 18: Hepatopatía aguda -- HEPATITIS VIRAL -- VIRUS DE LA HEPATITIS A -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- TRATAMIENTO -- VIRUS DE LA HEPATITIS B -- RESULTADOS/PRONÓSTICO -- VIRUS DE LA HEPATITIS C -- DIAGNÓSTICO -- TRATAMIENTO -- VIGILANCIA/SEGUIMIENTO -- EVOLUCIÓN/PRONÓSTICO -- VIRUS DE LA HEPATITIS D -- PRINCIPIOS GENERALES -- VIRUS DE LA HEPATITIS E -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- EVOLUCIÓN/PRONÓSTICO -- HEPATITIS POR VIRUS DEL HERPES SIMPLE -- PRINCIPIOS GENERALES -- DIAGNÓSTICO -- EVOLUCIÓN/PRONÓSTICO -- PARACETAMOL -- PRINCIPIOS GENERALES -- TRATAMIENTO…”

Tabla de Contenidos: “…Epidemiología y prevención de la hepatitis B -- 9. Vacunación frente a la hepatitis A -- 10. …”

Tabla de Contenidos: “…Ideal Experimental Rat Models for Liver Diseases -- Liver Transplantation in Liver Cirrhosis Patients Accompanied by Portal Vein Thrombosis -- Risk Factors for Intrahepatic Recurrence after Resection of Hepatocellular Carcinomas in Patients with Hepatitis B Virus Infection -- Outcome of Hepatectomy for Huge Hepatocellular Carcinoma -- Anatomical Variation of the Glissonean Pedicle of the Right Liver -- Effect of Liver Cell Transplantation on Acute Hepatic Failure Induced by Massive Liver Resection in the Rat -- Comparison of Bile Drainage Methods after Laparoscopic CBD Exploration -- Pancreatic Diabetes after Distal Pancreatectomy: Incidence Rate and Risk Factors -- Fat Tissue Infiltration into the Pancreas Parenchyme and Its Effect on the Result of Surgery -- Serous Cystic Neoplasm: Do We Have to Wait Till It Causes Trouble?…”

Tabla de Contenidos: “…Epidemiology in Military and Veteran Populations -- Copyright -- Preface -- Contents -- Means and Ends -- Synopses of Papers -- Yellow Fever Vaccine-Associated Hepatitis Epidemic During World War II:Follow-up More Than 40 Years... -- INTRODUCTION -- METHODS -- RESULTS -- Serologic Assay Results -- Hepatitis B Viral Antibody Markers: -- Hepatitis A Viral Antibody Markers: -- HBsAg, HBV Subtyping, Anti-HDV, and AFP: -- Concentration" of HBV Antibodies: -- Case-Control Mortality Data -- DISCUSSION -- ACKNOWLEDGMENTS -- Substance Use in World War II Veteran Twins: A Genetic Analysis -- BACKGROUND -- THE NAS-NRC TWIN REGISTRY -- SUBSTANCE USE IN THE NAS-NRC TWIN REGISTRY -- SUBSTANCE USE: ENVIRONMENTAL CORRELATES AND CO-OCCURENCE -- STATISTICAL METHODS -- BIVARIATE ASSOCIATIONS BETWEEN SMOKING, ALCOHOL USE, COFFEE CONSUMPTION, AND COVARIATES -- GENETIC ANALYSES -- Smoking -- Alcohol -- Coffee -- DISCUSSION -- Hemorrhagic Fever with Renal Syndrome: Past Accomplishments and Future Challenges -- Psychological Effects of Military Captivity -- ABSTRACT -- INTRODUCTION -- METHODS -- Subjects -- Measures -- RESULTS -- Military Captivity Data -- Demographic Data -- MMPI -- CES-D Scale -- Correlates of Depressive Symptoms -- Bivariate Relationships of Antecedent Variables and the CES-D -- Multivariate Relationships of Antecedent Variables and the CES-D -- Discussion -- Validity of the Data -- Symptoms and Diagnoses Contributing to the CES-D Scores -- CONCLUSIONS -- ACKNOWLEDGMENTS -- Dioxins and Dibenzofurans in Adipose Tissue of U.S. …”

“…It is recommended as a 12-week, single-tablet regimen for the treatment of chronic hepatitis C virus (HCV) infection for patients without cirrhosis or with compensated cirrhosis. …”

“…Metabolic disorders that are a consequence of hepatitis C virus infection are discussed in the succeeding chapter. …”

“…This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic hepatitis C. The development of direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection in 2010 has completely transformed the management of this disease. …”

Tabla de Contenidos: “…Introduction to biopharmaceutics and pharmacokinetics -- Mathematic fundamentals in pharmacokinetics -- Biostatistics -- One compartment open model : IV bolus injection -- Multicompartmental models : IV bolus injection -- Intravenous infusion -- Drug elimination and clearance -- Pharmacokinetics of oral absorption -- Multiple dosage regimens -- Nonlinear pharmacokinetics -- Physiologic drug distribution and protein binding -- Renal and hepatic elimination of drugs -- Pharmacogenetics and drug metabolism -- Physiologic factors related to drug absorption -- Biopharmaceutic considerations in drug product design -- Drug product performance, in vivo : bioavailability and bioequivalence -- Biopharmaceutic aspects of the active pharmaceutical ingredient and pharmaceutical equivalence -- Impact of biopharmaceutics on drug product quality and clinical efficacy -- Modified release drug products and drug devices -- Targeted drug delivery systems and biotechnology products -- Relationship between pharmacokinetic and pharmacodynamics -- Application of pharmacokinetics in clinical situations -- Application of pharmacokinetics in specific populations -- Dosage adjustment in renal and hepatic disease -- Empirical models, mechanistic models, statistical moment and noncompartmental analysis…”

Tabla de Contenidos: “…Chapter 6: Renal Elimination. Chapter 7: Hepatic Biotransformation and Biliary Excretion. Chapter 8: Compartmental Models. …”

Tabla de Contenidos: “…SÍNDROME HEPATORRENAL; 3. COMA HEPÁTICO; D. HEPATITIS VIRAL; 1. HEPATITIS VIRAL AGUDA; A. HEPATITIS A; B. …”

“…It deals with the acute and chronic inflammatory processes of the liver, among which is the viral hepatitis. Recently, very effective drugs have been introduced in this field that achieves the elimination of the hepatitis C virus in the great majority of patients. …”

“…Hepatocellular Carcinoma represents a leading cause of cancer death and a major health problem in developing countries where hepatitis B infection is prevalent. It has also become increasingly important with the increase in hepatitis C infection in developed countries. …”

Tabla de Contenidos: “…An unexpected diagnosis: hepatic fascioliasis. A case report and overview of the literature from Turkey…”

Tabla de Contenidos: “…Clinical pharmacokinetic and pharmacodynamic concepts -- Clinical pharmacokinetic calculations and equations -- Drug dosing in special populations : renal and hepatic disease, dialysis, heart failure, obesity, and drug interactions -- Aminoglycoside antibiotics -- Vancomycin -- Digoxin -- Lidocaine -- Procainamide/N-acetyl procainamide (NAPA) -- Quinidine -- Phenytoin/fosphenytoin -- Carbamazepine -- Valproic acid -- Phenobarbital/primidone -- Ethosuximide -- Lamotrigine -- Levetiracetam -- Oxcarbazepine/eslicarbazepine -- Cyclosporine -- Tacrolimus -- Sirolimus -- Lithium -- Theophylline…”

Tabla de Contenidos: “…A Note From NIDA's Director--Two Perspectives, One Goal--Editor's Note--Dialogue and Collaboration: A Path for Progress--Research Review--HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research--Response: Applying HIV Strategies to Hepatitis Prevention--The Neurobiology of Opioid Dependence: Implications for Treatment--Thomas R. …”

Tabla de Contenidos: “…Laboratory Quality Assurance and Safety -- 6.1 National quality assurance -- 6.2 Laboratory quality assurance -- 6.3 Safety procedures -- Appendix Standard Precautions for Prevention of Transmission of HIV, Hepatitis B Virus, Hepatitis C Virus and Other Bloodborne Pathogens in Health-Care Settings -- Glossary -- References…”